CUBO® (380mg)

Amenizar a distensão abdominal, comumente conhecida como efeito bloating;
• Reduzir a inflamação crônica de baixo grau;
• Aliviar desconfortos gastrointestinais;
• Modulação positiva da microbiota;
• Modulação positiva da permeabilidade intestinal. Vantagens
• Redução de 83% na distensão abdominal (efeito bloating);
• Redução de 80% no desconforto abdominal;
• Modulação positiva da microbiota intestinal, demonstrando uma redução de 50% nos níveis de Indican urinário.
Referências Bibliográficas

1. Materiais do fornecedor
2. Pellegrini, L., et al. "Managing ulcerative colitis in remission phase:
   usefulness of Casperome®, an innovative lecithin-based delivery system of
   Boswellia serrata extract." European review for medical and pharmacological
   sciences 20.12 (2016): 2695-2700.
3. Belcaro, G., et al. "Supplementation with a lecithin-based delivery form of
   Boswellia serrata extract (Casperome®) controls symptoms of mild irritable
   bowel syndrome." European Review for Medical and Pharmacological Sciences 21
   (2017): 2249-2254
4. Hüsch, Jan, et al. "Effect of phospholipid-based formulations of Boswellia
   serrata extract on the solubility, permeability, and absorption of the
   individual boswellic acid constituents present." Journal of natural products
   75.10 (2012): 1675-1682.
5. Hüsch, Jan, et al. "Enhanced absorption of boswellic acids by a lecithin
   delivery form (Phytosome®) of Boswellia extract." Fitoterapia 84 (2013):
   89-98.
6. Gerbeth, Kathleen, et al. "In vitro metabolism, permeation, and brain
   availability of six major boswellic acids from Boswellia serrata gum resins."
   Fitoterapia 84 (2013): 99-106.
7. Riva, Antonella, et al. "A single-dose, randomized, cross-over, two-way,
   open-label study for comparing the absorption of boswellic acids and its
   lecithin formulation." Phytomedicine 23.12 (2016): 1375-1382.
8. Di Pierro F, et al. "Clinical efficacy, safety and tolerability of BIO-curcumin®
   (Meriva®) in inflammatory bowel diseases: a systematic review and metaanalysis of randomized controlled trials." Pharmacol Res. 2020
   Jan;151:104582